| A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults (NCT06493461) | 35Pharma Inc | 2024-10-23 |
| Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis (NCT07490080) | Contipro Pharma a.s. | 2024-10-23 |
| A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma (NCT06716853) | Genenta Science | 2024-10-22 |
| Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated (NCT06613685) | Gilead Sciences | 2024-10-21 |
| A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation (NCT06599502) | AstraZeneca | 2024-10-18 |
| A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors (NCT06630247) | Exelixis | 2024-10-17 |
| Evaluation of Reflex Tear Production (NCT06565624) | Alcon Research | 2024-10-17 |
| A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (NCT06528093) | Boehringer Ingelheim | 2024-10-16 |
| Investigation of Low-intensity Focused Ultrasound Pressure (NCT06343883) | Virginia Polytechnic Institute and State University | 2024-10-16 |
| Study of ASN51 in Adults With Early Alzheimer's Disease (NCT06677203) | Asceneuron S.A. | 2024-10-16 |
| Exercise as Maintenance Therapy in Advanced Lung Cancer (NCT06513663) | Indiana University | 2024-10-15 |
| The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain (NCT06637527) | Okyo Pharma Ltd | 2024-10-15 |
| A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors (NCT06779851) | Bright Peak Therapeutics Inc | 2024-10-15 |
| Investigation of the Effects of Discharge Education Strategies on Quality of Life and Daily Living Activities in Patients Who Have Undergone Intracranial Surgery. (NCT07012681) | Bahçeşehir University | 2024-10-15 |
| AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment (NCT06611423) | AstraZeneca | 2024-10-15 |
| Post Approval Study to Evaluate the Safety and Performance of GENTA-FOIL Resorb® in Hand Surgery (NCT04482140) | Advanced Medical Solutions Ltd. | 2024-10-14 |
| LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT06558799) | NovoCure GmbH | 2024-10-14 |
| SAD and MAD Study of FTX-101 in Healthy Male Subjects (NCT06617546) | Find Therapeutics | 2024-10-14 |
| Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection (NCT06585150) | Gilead Sciences | 2024-10-14 |
| The Clostridioides Difficile Trial of REC-3964 (NCT06536465) | Recursion Pharmaceuticals Inc. | 2024-10-14 |
| Philips Non-Invasive Blood Pressure Validation Study (NCT06682312) | Philips Clinical & Medical Affairs Global | 2024-10-14 |
| An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors (NCT06568614) | BeOne Medicines | 2024-10-12 |
| FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis (NCT06566209) | Mayo Clinic | 2024-10-11 |
| Correlates of Fatigue in People With Schizophrenia (NCT06397950) | GCS CIPS | 2024-10-11 |
| First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers (NCT06625515) | Accent Therapeutics | 2024-10-11 |
| Natural History of Netherton Syndrome (NCT05902663) | Boehringer Ingelheim | 2024-10-09 |
| Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation (NCT06364215) | Jorge Romero | 2024-10-08 |
| M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) (NCT06509906) | EMD Serono Research & Development Institute, Inc. | 2024-10-08 |
| Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878 (NCT06607484) | SciRhom GmbH | 2024-10-08 |
| Nextsense Brain-sensing Buds Study (NCT06602960) | NextSense, Inc. | 2024-10-07 |
| Early Variations in Immune Aging (NCT06295354) | Radboud University Medical Center | 2024-10-07 |
| Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) (NCT06643117) | Formycon AG | 2024-10-03 |
| Evolution of the Lymphocyte Phenotype in Patients With Infection in Intensive Care Unit (NCT06415474) | University Hospital, Brest | 2024-10-03 |
| ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT06351644) | Adriana Rossi | 2024-10-02 |
| Comparing Effects of Conventional Neurorehabilitation With Exoskeleton With High-intensity Gait Training (NCT06478680) | Alvernia University | 2024-10-01 |
| Family-Based Meal Timing for Cancer Prevention Among Native Hawaiian and Other Pacific Islanders: FAMTIME (NCT07262593) | University of Utah | 2024-10-01 |
| Study of the Pharmacokinetics of Ceftriaxone (NCT07169097) | University Hospital, Rouen | 2024-09-30 |
| A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body (NCT06572111) | Boehringer Ingelheim | 2024-09-30 |
| A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers (NCT06523803) | Zymeworks BC Inc. | 2024-09-30 |
| --SuPERIOR Trial-- (NCT06191250) | University Health Network, Toronto | 2024-09-28 |
| Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD) (NCT06843187) | Unity Health Toronto | 2024-09-25 |
| Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio (NCT06570772) | Alvotech Swiss AG | 2024-09-23 |
| Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors (NCT06162663) | Medical University of South Carolina | 2024-09-20 |
| A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure (NCT06635135) | Janssen Research & Development, LLC | 2024-09-19 |
| Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease (NCT06622135) | Insight Research Institute | 2024-09-19 |
| Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns (NCT05856994) | Vanderbilt University Medical Center | 2024-09-19 |
| Topical ENS-002 for Atopic Dermatitis in Adults (NCT06469385) | Concerto Biosciences | 2024-09-18 |
| Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors (NCT06560632) | Repare Therapeutics | 2024-09-17 |
| Impact of Respiratory Training in Lymphoma Survivors (NCT05938127) | University of Colorado, Denver | 2024-09-16 |
| Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD (NCT06431256) | Ironshore Pharmaceuticals and Development, Inc | 2024-09-13 |
| Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial) (NCT05554354) | National Cancer Institute (NCI) | 2024-09-13 |
| Remote Trial - Tobacco Product Standard (VLNC) (NCT06442384) | Masonic Cancer Center, University of Minnesota | 2024-09-11 |
| Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] (NCT06150040) | Centre Leon Berard | 2024-09-11 |
| A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors (NCT06540066) | BeiGene | 2024-09-11 |
| ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension (NCT06418711) | Mannkind Corporation | 2024-09-11 |
| Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations (NCT06415968) | Centre Hospitalier Universitaire de Nīmes | 2024-09-10 |
| Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia (NCT05327985) | Fondation Ophtalmologique Adolphe de Rothschild | 2024-09-10 |
| A Study of MK-6552 and the Effect of Food in Healthy Participants (MK-6552-006) (NCT06567002) | Merck Sharp & Dohme LLC | 2024-09-09 |
| A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas (NCT06248086) | Astellas Pharma Global Development, Inc. | 2024-09-06 |
| CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes (NCT06611930) | Cytoki Pharma | 2024-09-06 |
| The Influence of Dry Needling for Hypertonia and Spasticity Treatment on Neuropathic Pain in Lower Extremity of Spinal Cord Injury: A Case Series Study (NCT06954688) | Universiteit Antwerpen | 2024-09-06 |
| A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. (NCT06546553) | Pfizer | 2024-09-06 |
| Study of Tazemetostat in Lymphoid Malignancies (NCT05983965) | University of Alabama at Birmingham | 2024-09-05 |
| A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088 (NCT06579300) | AbbVie | 2024-09-04 |
| A Study to Compare Nighttime Aligners to Daytime Aligners (NCT06539676) | Dentsply Sirona Implants and Consumables | 2024-09-04 |
| Clinical Investigation Evaluating the Use of NETSmart Solution , Incorporated to NETSoins Software, in the Care and Support of Elderly People Living in Nursing Homes (NCT07027358) | Teranga Software | 2024-09-03 |
| Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair (NCT06419855) | Top Health S.A.P.I DE C.V. | 2024-09-03 |
| DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (In Vivo Phase) (NCT05010369) | University of Exeter | 2024-09-02 |
| Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter (NCT06359379) | Shuttle Pharmaceuticals, Inc. | 2024-09-02 |
| Electromyographic Control of the Response in the Application of Vojta Therapy in People With Brain Injury. (NCT05785962) | University of Salamanca | 2024-09-01 |
| Maximizing the Reach of Universal Child Sexual Abuse Prevention: An Equivalence Trial (NCT06195852) | New York University | 2024-09-01 |
| Project QUIT+: Adapting and Testing a Smoking Cessation Intervention for Transgender and Gender Expansive Individuals (NCT06654414) | Massachusetts General Hospital | 2024-09-01 |
| Impact of Interactive ICU Diary on Psychological Distress (NCT06512987) | Taipei Medical University | 2024-09-01 |
| Post-market Clinical Follow-up Study of Alcon PRECISION1™ Spherical and PRECISION1™ for Astigmatism Soft Contact Lenses (NCT06462456) | Alcon Research | 2024-08-30 |
| Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT) (NCT06488820) | Texas Cardiac Arrhythmia Research Foundation | 2024-08-29 |
| Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS (NCT06524739) | CSL Behring | 2024-08-28 |
| Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors (NCT06573294) | Genmab | 2024-08-28 |
| Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control (NCT05088876) | Insel Gruppe AG, University Hospital Bern | 2024-08-28 |
| A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis (NCT06360094) | Boehringer Ingelheim | 2024-08-28 |
| Evaluation of Exotropia After Patching the Eye or After Prism Adaptation (NCT05242510) | University of Rochester | 2024-08-27 |
| Testing Educational Videos on Conservative Kidney Management (NCT06577571) | University of Washington | 2024-08-27 |
| A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma (NCT06407973) | Sight Sciences, Inc. | 2024-08-21 |
| A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome (NCT06544642) | Astellas Pharma Global Development, Inc. | 2024-08-21 |
| Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA (NCT06509958) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-08-20 |
| Investigating the Feasibility and Outcomes of Patient Self-Drain Removal After Ventral Hernia Repair (NCT06237855) | Wake Forest University Health Sciences | 2024-08-19 |
| A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT06198426) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-08-19 |
| Tributyrin: Time Course & Efficacy to Improve Health & Performance (NCT06501898) | Florida State University | 2024-08-19 |
| Ultrasonic Neuromodulation for Treatment of Cognitive Impairment (NCT06135051) | University of Utah | 2024-08-18 |
| Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) (NCT06045793) | Tonix Pharmaceuticals, Inc. | 2024-08-16 |
| The Impact of Abdominal Wall Reconstruction on Abdominal Wall Tension and Intra-Abdominal Pressure (NCT06575166) | The Cleveland Clinic | 2024-08-16 |
| Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens (NCT06479148) | Bausch & Lomb Incorporated | 2024-08-15 |
| Bone in CKD Alkali Response (BICARb Pilot Trial) (NCT05918029) | Albert Einstein College of Medicine | 2024-08-15 |
| EarGenie MVP Performance Evaluation (NCT06406088) | The Bionics Institute of Australia | 2024-08-15 |
| A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies (NCT06508489) | Sanofi | 2024-08-13 |
| Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1) (NCT06001125) | AHS Cancer Control Alberta | 2024-08-12 |
| Pilot - Resistance Exercise for Inpatient Treatment in T2D (NCT06547541) | Rigshospitalet, Denmark | 2024-08-12 |
| Metabolic Adaptations to High-fat Diet (NCT06537401) | George Washington University | 2024-08-12 |
| Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department (NCT06229353) | University of Alabama at Birmingham | 2024-08-08 |
| Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) (NCT06408168) | M.D. Anderson Cancer Center | 2024-08-08 |
| SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors (NCT06516926) | Jiangsu HengRui Medicine Co., Ltd. | 2024-08-08 |